Cefdinir
- Product NDC
- 52959-134
- 11-digit product format
- 529590134
- Labeler code
- 52959
- Product ID
- 52959-134_71d6b94b-c32f-441c-89d5-a105afab79ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- H.J. Harkins Company, Inc.
- Application
- ANDA065434
- Marketing category
- ANDA
- Marketing start
- 2008-08-23
- Marketing end
- 0000-00-00
- Substance
- CEFDINIR
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52959-134-20 | Cefdinir | 20 in 1 BOTTLE | CAPSULE | 20 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFDINIR | ACTIVE INGREDIENT | CI0FAO63WC | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| CEFDINIR | ACTIVE MOIETY | CI0FAO63WC | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52959-134 | CEFDINIR (CEFDINIR) CAPSULE [H.J. HARKINS COMPANY, INC.] | 1 | Legacy NDC, 1 package rows | 20110826_a3262279-1f9e-401b-9b02-6da3ef374b46.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 52959-134-20 | 52959013420 | 20 in 1 BOTTLE | Historical |